June 10 (Reuters) - Gilead Sciences Inc:
* Announces notification of anda filing for ranexa
* Says currently reviewing the notice letter
* Says has 45 days from the date of receipt to commence a patent infringement
lawsuit against Lupin
* Says such a lawsuit would restrict the FDA from approving Lupin's ANDA for up
to 30 months
* Says in the notice letter, Lupin alleges that all 10 patents associated with
Ranexa are invalid
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Announces notification of anda filing for ranexa
* Says currently reviewing the notice letter
* Says has 45 days from the date of receipt to commence a patent infringement
lawsuit against Lupin
* Says such a lawsuit would restrict the FDA from approving Lupin's ANDA for up
to 30 months
* Says in the notice letter, Lupin alleges that all 10 patents associated with
Ranexa are invalid
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2010 AFX News
